Current Status of Postoperative Radiation for Non-Small-Cell Lung Cancer

Basit Öğe Kaydı
dc.authoridHigginson, Daniel/0000-0002-6686-7454
dc.authoridHigginson, Daniel/0000-0002-6686-7454
dc.authorwosidHigginson, Daniel/AAW-4021-2020
dc.authorwosidHigginson, Daniel/X-8619-2018
dc.contributor.authorSaynak, Mert
dc.contributor.authorHigginson, Daniel S.
dc.contributor.authorMorris, David E.
dc.contributor.authorMarks, Lawrence B.
dc.date.accessioned2024-06-12T11:18:45Z
dc.date.available2024-06-12T11:18:45Z
dc.date.issued2010
dc.departmentTrakya Üniversitesien_US
dc.description.abstractRadiation therapy can increase local control and potentially improve survival in patients who have had resection for lung cancer. However, radiation therapy also has the potential to cause serious toxicity and should not be indiscriminately delivered. The PORT meta-analysis clearly illustrated the potential toxic effects of postoperative radiotherapy (PORT). Modern three-dimensional radiation treatment planning facilitates the design of treatment fields that more conformally treat the site(s) at risk, and this appears, based on limited data, to improve the therapeutic ratio of PORT. Moreover, systemic and local therapies are likely synergistic, and thus improvements in systemic staging and treatment may increase the ability of local therapies to improve overall survival. Therefore, a reassessment of the utility of postoperative radiation therapy using limited fields and modern techniques is warranted. Semin Radiat Oncol 20:192-200 (C) 2010 Elsevier Inc. All rights reserved.en_US
dc.description.sponsorshipTurkish Association of Radiation Oncologyen_US
dc.description.sponsorshipMert Saynak was funded by grants from the Turkish Association of Radiation Oncology.en_US
dc.identifier.doi10.1016/j.semradonc.2010.01.008
dc.identifier.endpage200en_US
dc.identifier.issn1053-4296
dc.identifier.issn1532-9461
dc.identifier.issue3en_US
dc.identifier.pmid20685582en_US
dc.identifier.scopus2-s2.0-77954842219en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage192en_US
dc.identifier.urihttps://doi.org/10.1016/j.semradonc.2010.01.008
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24948
dc.identifier.volume20en_US
dc.identifier.wosWOS:000279360800008en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherW B Saunders Co-Elsevier Incen_US
dc.relation.ispartofSeminars In Radiation Oncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDose-Volume Histogramen_US
dc.subjectResected Stage-Iien_US
dc.subjectProphylactic Cranial Irradiationen_US
dc.subjectVinorelbine Plus Cisplatinen_US
dc.subjectTrialist Association Anitaen_US
dc.subjectRandomized-Trialen_US
dc.subjectThoracic Radiotherapyen_US
dc.subjectAdjuvant Radiotherapyen_US
dc.subjectDosimetric Factorsen_US
dc.subjectPneumonitis Risken_US
dc.titleCurrent Status of Postoperative Radiation for Non-Small-Cell Lung Canceren_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu